- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 419/00 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 419/00
Total number of patents in this class: 96
10-year publication summary
|
7
|
1
|
2
|
5
|
1
|
1
|
0
|
0
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11234 |
5 |
| Janssen Pharmaceutica N.V. | 3610 |
5 |
| Merck Sharp & Dohme LLC | 3750 |
5 |
| Bristol-myers Squibb Company | 4864 |
3 |
| Bayer Cropscience AG | 2135 |
2 |
| Purdue Research Foundation | 3483 |
2 |
| Astex Therapeutics Limited | 250 |
2 |
| Hutchison MediPharma Enterprises Limited | 14 |
2 |
| Rigel Pharmaceuticals, Inc. | 586 |
2 |
| The University of Hong Kong | 717 |
2 |
| Impact Biomedicines, Inc. | 30 |
2 |
| Sumitomo Pharma Co., Ltd. | 637 |
2 |
| Hoffmann-La Roche Inc. | 3295 |
1 |
| The Regents of the University of California | 19590 |
1 |
| Genentech, Inc. | 3880 |
1 |
| Syngenta Participations AG | 3029 |
1 |
| Bayer Intellectual Property GmbH | 2566 |
1 |
| Amgen Inc. | 3911 |
1 |
| Merck Sharp & Dohme B.V. | 563 |
1 |
| BASF AG | 691 |
1 |
| Other owners | 54 |